Informations générales (source: ClinicalTrials.gov)
Economic Evaluation of Early Management of Sarcoma Patients by the Sarcoma Reference Network (NETSARC), Exploration of Organisational and Financial Constraints (OPTISARC)
Observational
Centre Leon Berard (Voir sur ClinicalTrials)
février 2021
février 2024
29 juin 2024
The aim of this project is to (1) evaluate the efficiency of early management of sarcoma
patients by the sarcoma referral network (NETSARC) vs. outside the network; (2) measure
the budgetary impact of the generalization of the most cost-effective strategy across the
country; (3) identify the organizational and financial constraints likely to hinder the
generalization of the most cost-effective strategy and propose solutions, and finally (4)
analyse the budgetary impact of a generalization of sarcoma patient care by the reference
network by integrating the organizational and financial solutions proposed.
The study relies on an exhaustive national cohort of all sarcoma patients who underwent
primary tumor surgery for the year 2013. Patients will be allocated to four distinct
strategies, each representing a different management of sarcoma patients who had a
sarcoma-specialized multidisciplinary tumor board (MDTB) before the initial surgery and
complete initial management in the network (strategy 1); patients who had a
sarcoma-specialized MDTB before the initial surgery and initial management outside the
network (strategy 2); patients who had a sarcoma-specialized MDTB after initial surgery
and initial management outside the network (strategy 3); patients who had an initial
management outside the network, without sarcoma-specialized MDTB neither before nor after
the initial surgery (strategy 4).
Matching of the National Health Data System (SNDS) and the NETSARC databases made it
possible to include 2431 patients in the study. These databases will allow to obtain
information on patients, estimate overall survival and identify healthcare consumption,
which will be useful in achieving study's objectives.
Etablissements
Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
---|---|---|---|---|---|
AP-HP - Hôpital Cochin | Philippe Anract, PU-PH | Contact (sur clinicalTrials) | |||
CLCC INSTITUT CURIE | Sophie Piperno-Neumann, MD | Contact (sur clinicalTrials) | |||
CLCC INSTITUT GUSTAVE ROUSSY | Axel Le Cesne, Prof. | Contact (sur clinicalTrials) | |||
Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
Centre Antoine Lacassagne - 06000 - Nice - France | Esma Saada, MD | Contact (sur clinicalTrials) | |||
Centre François Baclesse - 14000 - Caen - France | Sharmini Varatharajah, MD | Contact (sur clinicalTrials) | |||
Centre Georges François Leclerc - 21000 - Dijon - France | Sylvain Causeret, MD | Contact (sur clinicalTrials) | |||
Centre Henri Becquerel - 76000 - Rouen - France | Cécile Guillemet, MD | Contact (sur clinicalTrials) | |||
Centre Jean Perrin - 63000 - Clermont-Ferrand - France | Pascale Dubray-Longeras, MD | Contact (sur clinicalTrials) | |||
Centre Leon Berard - 69008 - Lyon - France | Jean-Yves Blay, PU-PH | Contact (sur clinicalTrials) | |||
Centre Oscar Lambret - 59000 - Lille - France | Nicolas PENEL, PU-PH | Contact (sur clinicalTrials) | |||
CHU Dupuytren - 87000 - Limoges - France | Fabrice Fiorenza, MD | Contact (sur clinicalTrials) | |||
CHU Jean Minjoz - 25000 - Besançon - France | Loic Chaigneau, MD | Contact (sur clinicalTrials) | |||
CHU Pontchaillou - 35000 - Rennes - France | Mickael Ropars, PU-PH | Contact (sur clinicalTrials) | |||
CHU Saint-Louis - 75000 - Paris - France | Céleste Lebbé, PU-PH | Contact (sur clinicalTrials) | |||
CHU Saint-Pierre - 97000 - La Réunion - France | Jean-Christophe Ruzic, MD | Contact (sur clinicalTrials) | |||
CHU Timone - 13000 - Marseille - France | Florence Duffaud, PU-PH | Contact (sur clinicalTrials) | |||
CHU Trousseau - 37000 - Tours - France | Philippe Rosset, PU-PH | Contact (sur clinicalTrials) | |||
ICM Val d'Aurelle - 34000 - Montpellier - France | Sébastien Carrère, MD | Contact (sur clinicalTrials) | |||
Institut Bergonié - 33000 - Bordeaux - France | Antoine Italiano, PU-PH | Contact (sur clinicalTrials) | |||
Institut de Cancérologie CHU Hautepierre - 67000 - Strasbourg - France | Jean-Emmanuel Kurtz, PU-PH | Contact (sur clinicalTrials) | |||
Institut de cancérologie de Lorraine - 54000 - Nancy - France | Maria Rios, MD | Contact (sur clinicalTrials) | |||
Institut de Cancérologie de l'Ouest - 44800 - Nantes - France | Emmanuelle Bompas, MD | Contact (sur clinicalTrials) | |||
Institut jean Godinot - 51000 - Reims - France | Pauline Soibinet-Oudot, MD | Contact (sur clinicalTrials) | |||
Institut Paoli Calmettes - 13000 - Marseille - France | François Bertucci, PU-PH | Contact (sur clinicalTrials) | |||
IUCT Institut Claudius Régaud - 31000 - Toulouse - France | Christine Chevreau, MD | Contact (sur clinicalTrials) |
Critères
Tous
Inclusion Criteria:
- Sarcoma diagnosis between 01/01/2013 and 31/12/2013
- International Classification of Diseases (ICD) code 10: C49 Malignant neoplasm of
other connective and soft tissue, or C48 Malignant neoplasm of retroperitoneum and
peritoneum, or C40-41 Malignant neoplasm of bone and articular cartilage of limbs)
- Surgery of the primary tumour.
- Sarcoma diagnosis between 01/01/2013 and 31/12/2013
- International Classification of Diseases (ICD) code 10: C49 Malignant neoplasm of
other connective and soft tissue, or C48 Malignant neoplasm of retroperitoneum and
peritoneum, or C40-41 Malignant neoplasm of bone and articular cartilage of limbs)
- Surgery of the primary tumour.
- Gastro intestinal stromal tumour
- Diagnosis not confirmed by the a second histological review